Skip to main content

Advertisement

SpringerLink
Log in

Expression of bleomycin hydrolase in keratinization disorders

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

A neutral cysteine protease, bleomycin hydrolase (BH), is widely expressed in mammalian tissues, with the skin seeming to contain the highest level. Our previous study revealed that BH transcription is modulated both during differentiation and by cytokines. However, BH involvement in keratinization disorder is not well known. In the present study, we performed immunohistochemical studies of BH and other serine/cysteine proteases in human normal skin and lesional skin with keratinization disorders. BH-positive cells were detected in granular layers of orthokeratotic and hyperkeratotic skin diseases, such as erythrokeratoderma and lichen planus. In parakeratotic skin diseases with porokeratosis, pityriasis rubra pilaris and psoriasis, BH staining was decreased in lesional skins compared to that in normal skin. Similar results were obtained for cysteine proteases, caspase-14 and calpain I. On the other hand, cells positive for serine proteases kallikrein 5 and 7 were increased in parakeratotic and inflammatory skin diseases, such as psoriasis. Semi-quantification analysis revealed that BH- and caspase-14-positive staining had higher intensity than those of the other proteases in normal epidermis. As BH is the major citrulline aminopeptidase in normal granular layer, the alternation would have a significant effect on terminal differentiation processes, such as aberrant processing of deiminated peptides. Therefore, BH may play an important role during the late stage of epidermal differentiation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Albert MR, Mackool BT (1999) Pityriasis rubra pilaris. Int J Dermatol 38:1–11

    Article  PubMed  CAS  Google Scholar 

  2. Bennett K, Callard R, Heywood W, Harper J, Jayakumar A, Clayman GL, Di WL, Mills K (2010) New role for LEKTI in skin barrier formation: label-free quantitative proteomic identification of caspase 14 as a novel target for the protease inhibitor LEKTI. J Proteome Res 9:4289–4294

    Article  PubMed  CAS  Google Scholar 

  3. Bikle DD, Pillai S (1993) Vitamin D, calcium, and epidermal differentiation. Endocr Rev 14:3–19

    PubMed  CAS  Google Scholar 

  4. Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, Guy RH, Macgowan AL, Tazi-Ahnini R, Ward SJ (2009) Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 129:1892–1908

    Article  PubMed  CAS  Google Scholar 

  5. Denecker G, Hoste E, Gilbert B, Hochepied T, Ovaere P, Lippens S, Van den Broecke C, Van Damme P, D’Herde K, Hachem JP, Borgonie G, Presland RB, Schoonjans L, Libert C, Vandekerckhove J, Gevaert K, Vandenabeele P, Declercq W (2007) Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol 9:666–674

    Article  PubMed  CAS  Google Scholar 

  6. Denecker G, Ovaere P, Vandenabeele P, Declercq W (2008) Caspase-14 reveals its secrets. J Cell Biol 180:451–458

    Article  PubMed  CAS  Google Scholar 

  7. Ekholm IE, Brattsand M, Egelrud T (2000) Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process? J Invest Dermatol 114:56–63

    Article  PubMed  CAS  Google Scholar 

  8. Fallon PG, Sasaki T, Sandilands A, Campbell LE, Saunders SP, Mangan NE, Callanan JJ, Kawasaki H, Shiohama A, Kubo A, Sundberg JP, Presland RB, Fleckman P, Shimizu N, Kudoh J, Irvine AD, Amagai M, McLean WH (2009) A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 41:602–608

    Article  PubMed  CAS  Google Scholar 

  9. Hattori A, Tsujimoto M (2004) Processing of antigenic peptides by aminopeptidases. Biol Pharm Bull 27:777–780

    Article  PubMed  CAS  Google Scholar 

  10. Hsu CY, Henry J, Raymond AA, Méchin MC, Pendaries V, Nassar D, Hansmann B, Balica S, Burlet-Schiltz O, Schmitt AM, Takahara H, Paul C, Serre G, Simon M (2011) Deimination of human filaggrin-2 promotes its proteolysis by calpain 1. J Biol Chem 286:23222–23233

    Article  PubMed  CAS  Google Scholar 

  11. Hvid M, Johansen C, Deleuran B, Kemp K, Deleuran M, Vestergaard C (2011) Regulation of caspase 14 expression in keratinocytes by inflammatory cytokines—a possible link between reduced skin barrier function and inflammation? Exp Dermatol 20:633–636

    Article  PubMed  CAS  Google Scholar 

  12. Ishida-Yamamoto A, Senshu T, Takahashi H, Akiyama K, Nomura K, Iizuka H (2000) Decreased deiminated keratin K1 in psoriatic hyperproliferative epidermis. J Invest Dermatol 114:701–705

    Article  PubMed  CAS  Google Scholar 

  13. Ishida-Yamamoto A, Senshu T, Eady RA, Takahashi H, Shimizu H, Akiyama M, Iizuka H (2002) Sequential reorganization of cornified cell keratin filaments involving filaggrin-mediated compaction and keratin 1 deimination. J Invest Dermatol 118:282–287

    Article  PubMed  CAS  Google Scholar 

  14. Kamata Y, Taniguchi A, Yamamoto M, Nomura J, Ishihara K, Takahara H, Hibino T, Takeda A (2009) Neutral cysteine protease bleomycin hydrolase is essential for the breakdown of deiminated filaggrin into amino acids. J Biol Chem. 284:12829–12836

    Article  PubMed  CAS  Google Scholar 

  15. Kamata Y, Itoh Y, Kajiya A, Karasawa S, Sakatani C, Takekoshi S, Osamura RY, Takeda A (2007) Quantification of neutral cysteine protease bleomycin hydrolase and its localization in rat tissues. J Biochem 141:69–76

    Article  PubMed  CAS  Google Scholar 

  16. Kamata Y, Yamamoto M, Kawakami F, Tsuboi R, Takeda A, Ishihara K, Hibino T (2011) Bleomycin hydrolase regulated biphasically in a differentiation- and cytokine-dependent manner—relevance to atopic dermatitis. J Biol Chem. 286:8204–8212

    Article  PubMed  CAS  Google Scholar 

  17. Komatsu N, Saijoh K, Toyama T, Ohka R, Otsuki N, Hussack G, Takehara K, Diamandis EP (2005) Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases. Br J Dermatol 153:274–281

    Article  PubMed  CAS  Google Scholar 

  18. Lefterov IM, Koldamova RP, Lazo JS (2000) Human bleomycin hydrolase regulates the secretion of amyloid precursor protein. FASEB J. 14:1837–1847

    Article  PubMed  CAS  Google Scholar 

  19. List K, Szabo R, Wertz PW, Segre J, Haudenschild CC, Kim SY, Bugge TH (2003) Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. J Cell Biol 163:901–910

    Article  PubMed  CAS  Google Scholar 

  20. Matsushita Y, Shimada Y, Kawara S, Takehara K, Sato S (2005) Autoantibodies directed against the protease inhibitor calpastatin in psoriasis. Clin Exp Immunol 139:355–362

    Article  PubMed  CAS  Google Scholar 

  21. Maubec E, Duvillard P, Margulis A, Bachollet B, Degois G, Avril MF (2005) Common skin cancers in porokeratosis. Br J Dermatol 152:1389–1391

    Article  PubMed  CAS  Google Scholar 

  22. McGrath JA, Uitto J (2008) The filaggrin story: novel insights into skin-barrier function and disease. Trends Mol Med. 14:20–27

    Article  PubMed  CAS  Google Scholar 

  23. Meyer-Hoffert. (2009) Reddish, scaly, and itchy: how proteases and their inhibitors contribute to inflammatory skin diseases. Arch Immunol Ther Exp 57:345–354

    Article  CAS  Google Scholar 

  24. Miyachi Y, Yoshimura N, Suzuki S, Hamakubo T, Kannagi R, Imamura S, Murachi T (1986) Biochemical demonstration and immunohistochemical localization of calpain in human skin. J Invest Dermatol 86:346–349

    Article  PubMed  CAS  Google Scholar 

  25. Montoya SE, Aston CE, DeKosky ST, Kamboh MI, Lazo JS, Ferrell RE (1998) Bleomycin hydrolase is associated with risk of sporadic Alzheimer’s disease. Nat Genet 18:211–212

    Article  PubMed  CAS  Google Scholar 

  26. Namba Y, Ouchi Y, Takeda A, Ueki A, Ikeda K (1999) Bleomycin hydrolase immunoreactivity in senile plaque in the brains of patients with Alzheimer’s disease. Brain Res 830:200–202

    Article  PubMed  CAS  Google Scholar 

  27. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496–509

    Article  PubMed  CAS  Google Scholar 

  28. Ossovskaya VS, Bunnett NW (2004) Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84:579–621

    Article  PubMed  CAS  Google Scholar 

  29. Ovaere P, Lippens S, Vandenabeele P, Declercq W (2009) The emerging roles of serine protease cascades in the epidermis. Trends Biochem Sci 34:453–463

    Article  PubMed  CAS  Google Scholar 

  30. Pistritto G, Jost M, Srinivasula SM, Baffa R, Poyet JL, Kari C, Lazebnik Y, Rodeck U, Alnemri ES (2002) Expression and transcriptional regulation of caspase-14 in simple and complex epithelia. Cell Death Differ 9:995–1006

    Article  PubMed  CAS  Google Scholar 

  31. Presland RB, Boggess D, Lewis SP, Hull C, Fleckman P, Sundberg JP (2000) Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. J Invest Dermatol 115:1072–1081

    Article  PubMed  CAS  Google Scholar 

  32. Saido TC, Sorimachi H, Suzuki K (1994) Calpain: new perspectives in molecular diversity and physiological–pathological involvement. FASEB J. 8:814–822

    PubMed  CAS  Google Scholar 

  33. Sandilands A, Sutherland C, Irvine AD, McLean WH (2009) Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 122:1285–1294

    Article  PubMed  CAS  Google Scholar 

  34. Schwartz DR, Homanics GE, Hoyt DG, Klein E, Abernethy J, Lazo JS (1999) The neutral cysteine protease bleomycin hydrolase is essential for epidermal integrity and bleomycin resistance. Proc Natl Acad Sci USA 96:4680–4685

    Article  PubMed  CAS  Google Scholar 

  35. Shen CS, Tabata K, Matsuki M, Goto T, Yokochi T, Yamanishi K (2002) Premature apoptosis of keratinocytes and the dysregulation of keratinization in porokeratosis. Br J Dermatol 147:498–502

    Article  PubMed  Google Scholar 

  36. Stoltze L, Schirle M, Schwarz G, Schröter C, Thompson MW, Hersh LB, Kalbacher H, Stevanovic S, Rammensee HG, Schild H (2000) Two new proteases in the MHC class I processing pathway. Nat Immunol. 1:413–418

    Article  PubMed  CAS  Google Scholar 

  37. Takeda A, Nonaka M, Ishikawa A, Higuchi D (1999) Immunohistochemical localization of the neutral cysteine protease bleomycin hydrolase in human skin. Arch Dermatol Res 291:238–240

    Article  PubMed  CAS  Google Scholar 

  38. Umezawa H, Hori S, Sawa T, Yoshioka T, Takeuchi T (1974) A bleomycin-inactivating enzyme in mouse liver. J Antibiot (Tokyo) 27:419–424

    CAS  Google Scholar 

  39. Van de Craen M, Van Loo G, Pype S, Van Criekinge W, Van den brande I, Molemans F, Fiers W, Declercq W, Vandenabeele P (1998) Identification of a new caspase homologue: caspase-14. Cell Death Differ 5:838–846

    Article  PubMed  Google Scholar 

  40. Zeeuwen PL (2004) Epidermal differentiation: the role of proteases and their inhibitors. Eur J Cell Biol 83:761–773

    Article  PubMed  CAS  Google Scholar 

  41. Yoshimura N, Kikuchi T, Sasaki T, Kitahara A, Hatanaka M, Murachi T (1983) Two distinct Ca2+ proteases (calpain I and calpain II) purified concurrently by the same method from rat kidney. J Biol Chem. 258:8883–8889

    PubMed  CAS  Google Scholar 

  42. Zimny J, Sikora M, Guranowski A, Jakubowski H (2006) Protective mechanisms against homocysteine toxicity: the role of bleomycin hydrolase. J Biol Chem. 281:22485–22492

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Regulation Biochemistry, Graduate School of Medical Sciences, Kitasato University, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0373, Japan

    Yayoi Kamata & Kazuhiko Ishihara

  2. Department of Dermatology, School of Medicine, Kitasato University, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan

    Hideki Maejima, Akira Watarai, Norimitsu Saito & Kensei Katsuoka

  3. Laboratory of Biochemistry, Graduate School of Nutritional Sciences, Sagami Women’s University, 2-1-1 Bunkyo, Minami-ku, Sagamihara, Kanagawa, 252-0383, Japan

    Atsushi Takeda

Authors
  1. Yayoi Kamata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hideki Maejima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Akira Watarai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Norimitsu Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kensei Katsuoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Atsushi Takeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kazuhiko Ishihara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazuhiko Ishihara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kamata, Y., Maejima, H., Watarai, A. et al. Expression of bleomycin hydrolase in keratinization disorders. Arch Dermatol Res 304, 31–38 (2012). https://doi.org/10.1007/s00403-011-1180-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-011-1180-6

Keywords

Search

Navigation